Skip to main content

Table 4 Tenascin-C transcript levels in carcinomas stratified by age

From: Association of invasion-promoting tenascin-C additional domains with breast cancers in young women

   Number of molecules Mean
Age Sample Total TNC TNC-AD1 TNC-AD2 Total TNC TNC-AD1 TNC-AD2
≤40 years T1 1,212,265 52,620 0 143,696,985 8,944,007 2,027,925
  T2 99,024,132 1,567,084 0 (P = 0.005) (P = 0.030)  
  T3 2,088,668 150,030 118,774    
  T4 958,188 58,137 0    
  T5 4,701,400 0 0    
  T6 14,962,216 0 0    
  T7 11,837,854 197,415 0    
  T8 339,673 0 0    
  T9 192,103,000 17,251,715 11,618,505    
  T10 1,100,396,396 79,107,073 10,569,893    
  T11 153,043,046 0 0    
>40 years T12 37,859,646 0 0 4,677,309 25,914 2,211
  T13 208,821 37,702 24,325    
  T14 7,992,309 0 0    
  T15 66,360 7,451 0    
  T16 897,614 0 0    
  T17 73,244 0 0    
  T18 1,206,237 229,110 0    
  T19 168,882 9,045 0    
  T20 276,036 0 0    
  T21 6,970 1,746 0    
  T22 2,694,279 0 0    
  1. Normalised expression of tenascin-C (TNC) molecules in carcinomas from women aged ≤40 years and >40 years. Mann-Whitney tests were used to calculate P values.